Formerly IMI International Medical Innovations. PreMD Inc., a predictive medicine company, empowers patients and physicians alike with simple, non-invasive tests that detect early-stage cardiovascular disease and cancer. Our mission is to prevent life-threatening illnesses and promote long-term health and wellness.
This test non-invasively measures cholesterol in the skin tissues to assess risk of heart disease.

This minimally invasive, painless test for colorectal cancer, currently in development, has several advantages over FOBT.

 

4/07/09

PreMD Closes Debt Financing Facility

2/26/09

PreMD Announces Resignation of Director

2/26/09

PreMD Reduces Staffing, Operations - FDA Appeal Still in Process

2/05/09

Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers

 

 

   

 

LungAlert™, currently in development, is non-invasive, inexpensive and may be more effective than other tests at detecting early-stage lung cancer.
This simple, non-invasive test, currently in development, has been shown to detect early-stage breast cancer.
Click here for detailed stock quote and chart information.
© Copyright 2007 All Rights Reserved